Agomab Therapeutics (AGMB) Short-term Investments (2025)

Agomab Therapeutics' Short-term Investments history runs 1 years deep, the most recent figure standing at $35.0 million for Q4 2025.

• In Q4 2025, Short-term Investments changed N/A year-over-year to $35.0 million; the TTM figure through Dec 2025 stood at $35.0 million (changed N/A YoY), while the FY2025 annual figure was $35.0 million, changed N/A from the prior year.
• Short-term Investments for Q4 2025 stood at $35.0 million.
• The five-year high for Short-term Investments was $35.0 million in Q4 2025, with the low at $35.0 million in Q4 2025.